| Primary information |
|---|
| sequence ID | Seq_513 |
| Peptide sequence | ALEEYTKKLNTQ |
| CancerPDF_ID | CancerPDF_ID75, CancerPDF_ID3442, CancerPDF_ID3577, |
| PMID | 16896061,27026199,27026199 |
| Protein Name | Apolipoprotein A-I,Apolipoprotein A-I,Apolipoprotein A-I |
| UniprotKB Entry Name | APOA1_HUMAN,APOA1_HUMAN,APOA1_HUMAN |
| Fluid | Serum,Urine,Urine |
| M/Z | 719.43,NA,NA |
| Charge | 1,NA,NA |
| Mass (in Da) | 1437.75,NA,NA |
| fdr | NA,1436.73,1436.75 |
| Profiling Technique | MALDI-TOF,"CE-MS, Micro-TOF-MS","CE-MS, Micro-TOF-MS" |
| Peptide Identification technique | Q/TOF MS/MS,MS-MS,MS-MS |
| Quantification Technique | NA,NA,NA |
| Labelled/Label Free | Label Free,Label Free,Label Free |
| FDR | NA,NA,NA |
| CancerPDF_ID | CancerPDF_ID75, CancerPDF_ID3442, CancerPDF_ID3577, |
| p-Value | 1.00E-05,less than 0.05,less than 0.001 |
| Software | MASCOT,Proteome Discoverer 1.2,Proteome Discoverer 1.2 |
| Length | 12,12,12 |
| Cancer Type | Metastatic thyroid carcinomas,Bladder cancer,Bladder cancer |
| Database | NCBI refseq Protein Database,Uniprot Human non-redundant Database,Uniprot Human non-redundant Database |
| Modification | NA,NA,NA |
| Number of Patients | 40 metastatic thyroid carcinoma patients and 40 normal for training phase and 10 metastatic thyroid carcinoma and 10 normal individuals for independent validation,451 for training (341 patients and 110 normal) and 270 for testing(168 primary UBC patients and 102 normal controls);, 425 for training(109 patients with Recurrent UBC cases and 316 negative for recurrence controls) and 211 for validation (55 UBC recurrent cases and 156 recurrent controls) |
| Regulation | NA,Differentially expressed between primary UBC and normal individual,Differentially expressed between recurrence of UBC vs recurrence control |
| Validation | Independent validation,Independent Validation,Independent Validation |
| Sensitivity | 95% on independent dataset,For testing dataset 91%,For testing dataset 88% |
| Specificity | 95% on independent dataset,For testing dataset 68%,For testing dataset 51% |
| Accuracy | NA,For testing dataset 76%,NA |
| Peptide Atlas | NA |
| IEDB | 120086
|